If you need help accessing our website, call 855-698-9991
Skip to main content
NYU Langone Provider

Kara R. Melmed, MD

NYU Langone Provider
  • Specialty: Neuro-Critical Care
  • Treats: Adults
  • Language: English
  • Phone: 212-263-7300
View Locations

Board Certifications
  • American Board of Psychiatry & Neurology - Neurology, 2017
Education and Training
  • Fellowship, New York-Presbyterian/Columbia University Medical Center, Neurocritical Care, 2019
  • Residency, Cedars-Sinai Medical Center, Neurology, 2017
  • MD from University Of Arizona, 2013

Is this your profile?

Edit profile

This provider accepts the following insurance plans.

  • Aetna
     
    • Aetna HMO
    • Aetna Indemnity
    • Aetna Medicare
    • Aetna POS
    • Aetna PPO/EPO
  • Agewell
     
    • Agewell
  • Amidacare
     
    • Amidacare
  • Centerlight
     
    • Centerlight
  • Cigna
     
    • Cigna EPO/POS
    • Cigna PPO
  • ElderPlan
     
    • ElderPlan
  • Emblem
     
    • Emblem Select Care Exchange
  • Empire Blue Cross Blue Shield
     
    • Empire Blue Cross Blue Shield EPO
    • Empire Blue Cross Blue Shield HMO
    • Empire Blue Cross Blue Shield HealthPlus
    • Empire Blue Cross Blue Shield HealthPlus Essential
    • Empire Blue Cross Blue Shield Indemnity
    • Empire Blue Cross Blue Shield MediBlue
    • Empire Blue Cross Blue Shield POS
    • Empire Blue Cross Blue Shield PPO
  • Fidelis
     
    • Fidelis Child Health
    • Fidelis Essential
    • Fidelis Exchange
    • Fidelis Medicaid
    • Fidelis Medicare
  • GHI
     
    • GHI CBP
    • GHI HMO
View All Accepted Plans This list of insurances changes regularly, and insurance plans listed may not be accepted at all office locations for this provider. Before your appointment, please confirm with your insurance company that this provider accepts your insurance.

Kara R. Melmed, MD does not accept insurance.

Locations and Appointments

NYU Neurology Associates

550 1st Avenue, New York, NY 10016

Phone

212-263-7300

Fax

212-263-7721

  • CHARM: Glibenclamide for Large Hemispheric Infarction Analyzing mRS and Mortality. A Multicenter Double-Blind Placebo-Controlled Randomized Parallel-Group Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 for Severe Cerebral Ed

    Learn More
View All Research Studies (1)

Read All Publications (50)

Related News